Yes , my blurry eyed morning self meant to say.
Potency assay approval will lead to manufacturing at scale.
That manufacturing at scale creates a valuation.
That valuation may be used in calculations of a takeover offer.
I expect Novartis will swallow Rem-L whole, if not all of Mesoblast.
Reg
Yes , my blurry eyed morning self meant to say. Potency assay...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |